Active substanceNaphthyfinNaphthyfin
Similar drugsTo uncover
  • Mizol® Evalar
    solution externally 
    EVALAR, CJSC     Russia
  • Mikoderil®
    cream externally 
    OTISIFARM, OJSC     Russia
  • Mikoderil®
    solution externally 
    OTISIFARM, OJSC     Russia
  • Naphthyfin
    solution externally 
  • Naphthyfin
    cream externally 
  • Exoderyl®
    solution externally 
    Sandoz GmbH     Austria
  • Exoderyl®
    cream externally 
    Sandoz GmbH     Austria
  • Exostat
    solution externally 
    VERTEKS, AO     Russia
  • Exostat
    cream externally 
    VERTEKS, AO     Russia
  • Dosage form: & nbspRA mortar for external use.
    Composition:

    1 ml of the solution contains:

    active substance: naftifin hydrochloride 10.0 mg;

    Excipients: propylene glycol 50.0 mg; ethanol 95% (ethyl alcohol 95%) - 400.0 mg; purified water - up to 1 ml.

    Description:

    A clear, colorless or light yellow solution with the smell of ethanol.

    Pharmacotherapeutic group:antifungal agent
    ATX: & nbsp

    D.01.A.E.22   Naphthyfin

    Pharmacodynamics:

    Naphthyfine is an antifungal agent for external use, which belongs to the class of allylamines. The mechanism of action is associated with the inhibition of squalene-2,3-epoxidase, which leads to a decrease in the formation of ergosterol, which is part of the cell wall of the fungus.

    Active with respect to dermatophytes, such as Trichophyton, Epidermophyton, Microsporum, molds (Aspergillus spp.), yeast fungi (Candida spp., Pityrosporum) and other fungi (for example, Sporothrix schenckii). For dermatophytes and aspergillas naphthyline is fungicidal.

    Regarding yeast fungi naphthyline shows fungicidal or fungistatic activity, depending on the strain of the microorganism.

    Has antibacterial activity against Gram-positive and Gram-negative microorganisms, which can cause secondary bacterial infections.

    Has an anti-inflammatory effect, which contributes to the rapid disappearance of symptoms of inflammation, especially itching.

    Pharmacokinetics:

    With external application naphthyline well penetrates the skin, creating stable antifungal concentrations in its various layers, which makes it possible to use the drug once a day.

    Indications:

    - Fungal infections of skin and skin folds (tinea corporis, tinea inquinalis);

    - interdigital mycoses (tinea manum, tinea pedum);

    - fungal infections of the nails (onychomycosis);

    - candidiasis of the skin;

    - multicolored (lichen);

    - dermatomycosis (with or without accompanying itching).

    Contraindications:

    - Hypersensitivity to naphthyfine or other components of the drug;

    - pregnancy and the period of breastfeeding (safety and efficacy not established);

    - application to the wound surface.

    Carefully:

    Children's age (clinical experience is limited).

    Pregnancy and lactation:

    Application of the drug Exostat during pregnancy and during breastfeeding is contraindicated (the safety and efficacy of naphthyfine in this category of patients has not been studied).

    Dosing and Administration:

    Outwardly.

    When skin is affected

    The drug Exostat is applied once a day to the affected surface of the skin and the adjacent areas (approximately 1 cm of a healthy area of ​​the skin along the edges of the affected area) after they have been thoroughly cleaned and dried.

    Duration of therapy for dermatomycosis - 2-4 weeks (if necessary, up to 8 weeks), with candidiasis - 4 weeks.

    When the nails are affected

    The drug Exostat applied 2 times a day on the affected nail. Before the first use of the drug, remove the affected part of the nail with scissors or a nail file.

    The duration of therapy with onychomycosis is up to 6 months.

    To prevent recurrence, treatment should be continued for at least 2 weeks after the disappearance of clinical symptoms.

    Side effects:

    In some cases, local reactions can occur: dry skin, skin hyperemia (redness) and burning.

    Side effects are reversible and do not require withdrawal of treatment.

    If any of the side effects indicated in the manual are aggravated, or any other side effects not indicated in the instructions are noted, you should inform the doctor immediately.

    Overdose:

    No cases of overdose have been reported.

    Interaction:

    Interaction with other drugs has not been studied.

    Special instructions:

    The drug Exostat is not intended for use in ophthalmology. Do not allow the product to enter the eyes.

    To achieve a therapeutic effect, course treatment is required.

    The drug Exostat is effective in the treatment of fungal infections affecting the skin area with hyperkeratosis, as well as in areas of hair growth.

    Propylene glycol, which is part of the solution, can cause skin irritation; If side effects occur, discontinue use and consult a doctor.

    Effect on the ability to drive transp. cf. and fur:

    The drug Exostat does not adversely affect the ability to drive vehicles and perform otherActivities that require concentration and speed of psychomotor reactions.

    Form release / dosage:

    Solution for external use, 1%.

    Packaging:

    10 ml, 15 ml or 20 ml in dark glass bottles sealed with low-density polyethylene capsules and screw caps of high-density polyethylene with control of the first opening.

    Each vial with instructions for use in a pack of cardboard.

    Storage conditions:

    Store at a temperature not exceeding 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after expiry date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-003666
    Date of registration:06.06.2016
    Expiration Date:06.06.2021
    The owner of the registration certificate:VERTEKS, AO VERTEKS, AO Russia
    Manufacturer: & nbsp
    Representation: & nbspVERTEKS CJSC VERTEKS CJSC Russia
    Information update date: & nbsp23.07.2016
    Illustrated instructions
      Instructions
      Up